A PYMNTS Company

Americas: Pharma’s $438M deal extends Bristol-Myers drugs to Latin America

By  |  February 12, 2013

New York-based pharmaceutical giant Bristol-Myers Squibb has reportedly signed a deal worth $438 million with Reckitt Benckiser, a personal health products company based in the UK. According to reports, the deal will last for three years an includes an agreement to a $44 million option fee, giving Reckitt the option of buying Bristol-Myers brands at the end of the three years. The contract gives Bristol-Myers control over Reckitt manufacturing and, in turn, allows Reckitt to sell Bristol-Myers medicines throughout Latin America, especially Mexico and Brazil. Mexico and Brazil antitrust authorities may review the deal, however.

 

Full Content: Fox News

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.